PROFOUND MEDICAL CORP. Cash and Restricted Cash
PROFOUND MEDICAL CORP. (PROF) had Cash and Restricted Cash of $38.27 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-06
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $38.27M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $50.30M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $59.72M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $24.83M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $38.27M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $50.30M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $59.72M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $24.83M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $35.20M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $46.43M 10-Q · filed 2026-05-07 |
| 2024-12-31 | $54.91M 10-Q · filed 2026-08-06 |
| 2024-09-30 | $27.12M 10-Q · filed 2025-11-13 |
| 2024-06-30 | $34.08M 10-Q · filed 2025-08-14 |
| 2024-03-31 | $41.18M 10-Q · filed 2025-05-08 |
| 2023-12-31 | $26.21M 10-K · filed 2026-03-05 |
| 2022-12-31 | $46.52M 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |